M

Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager
Magle Chemoswed Holding AB
STO:MAGLE
Watchlist
Price: 17.1 SEK Market Closed
Market Cap: 353.1m SEK

Net Margin
Magle Chemoswed Holding AB

-7.1%
Current
5%
Average
1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-7.1%
=
Net Income
-20.2m
/
Revenue
285.6m

Net Margin Across Competitors

No Stocks Found

Magle Chemoswed Holding AB
Glance View

Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

MAGLE Intrinsic Value
40.92 SEK
Undervaluation 58%
Intrinsic Value
Price
M
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-7.1%
=
Net Income
-20.2m
/
Revenue
285.6m
What is the Net Margin of Magle Chemoswed Holding AB?

Based on Magle Chemoswed Holding AB's most recent financial statements, the company has Net Margin of -7.1%.

Back to Top